SCHEMBL7119744

SCHEMBL7119744

NC(=O)c1cncnc1NCc1ccncc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.62
RPS6KB1 P23443 13/20 0.50
AKT1 P31749 2/20 0.50
JAK2 O60674 1/20 0.50
JAK1 P23458 1/20 0.50
JAK3 P52333 1/20 0.50
AURKA O14965 11/20 0.49
AURKB Q96GD4 2/20 0.46
CDC7 O00311 1/20 0.46
ROCK2 O75116 1/20 0.46
MAP4K4 O95819 1/20 0.46
GSK3B P49841 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3712006 0.89 RPS6KB1 (0.63) KDRRPS6KB1AKT1JAK2JAK1
SCHEMBL1466583 0.83 KDR (0.60) KDRCLK4HDAC3HDAC1HDAC2
SCHEMBL5261234 0.81 KDR (0.62) KDRRPS6KB1CDC7ROCK2MAP4K4
SCHEMBL30595572 0.81 KDR (0.62) KDRRPS6KB1CDC7ROCK2MAP4K4
SCHEMBL22261196 0.80 JAK3 (0.55) KDRJAK2JAK1JAK3CDC7
SCHEMBL7126529 0.77 JAK3 (0.58) JAK2JAK1JAK3
SCHEMBL5718472 0.76 KDM4C (0.66) CDC7ROCK2MAP4K4GSK3BCLK4
SCHEMBL29622796 0.76 RPS6KB1 (0.64) RPS6KB1AKT1JAK2JAK1JAK3
SCHEMBL429092 0.75 KDR (0.78) KDR
SCHEMBL29622729 0.75 CYP1A2 (0.58) RPS6KB1AKT1JAK3AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 EP disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO disclosed